Bioinformatics tools are largely used in the field of drug discovery and help to collect and organize data for analyzing and visualizing biomolecular structures. The growing importance of drug safety and increasing regulations in the field of clinical trials has forced pharmaceutical companies to introduce effective technologies for the development of successful therapies. Increases in the number of drugs being researched and the introduction of new drug development techniques have resulted in a proliferation of data. Bioinformatics helps to make time and cost savings in the process of drug discovery by offering effective visualization of the data. The need for better quality of output has encouraged bioinformatics firms to create enhanced tools for application in diseases such as cancer and the increasing importance of personalized medicine has boosted research into pharmacogenomics. This has resulted in the development of more effective and innovative bioinformatic tools, especially in the field of molecular medicine. This report segments the bioinformatics market on a number of levels: tools, services, content/database, applications and region, providing market forecasts to 2014. In addition to analyzing market drivers and resistors, and highlighting other applications of bioinformatics. The report also provides profiles of 55 bioinformatics companies, including recent deals, collaborations and product launches.